eyesON | R&D Efficiency: Big Pharma Overview
Explore the R&D efficiency and it's return on investment of the biggest publicly traded pharma companies.
Jan
2024
Oct
2023
eyesON | Happymeter: Decoding Happiness
Happymeter: Decoding Happiness - we measured what makes us happy! Explore global joy and key happiness contributors using data insights.
Sep
2023
eyesON | Economy & Health
Explore the intricate balance between economy and well-being. Discover how country's GDP and health expenditure influence core health outcomes.
Sep
2023
Vanguard vs. Big Pharma: Research Focus & Recruitment
Explore how Vanguard companies, innovative small pharma entities, differ in research focus and recruitment dynamics from larger Pharma.
Jul
2023
eyesON | Phase II Vanguards
Phase II Vanguards data visualization tool provides oversight of groundbreaking investigational new drugs and under-the-radar institutions developing them.
Jun
2023
The Technology Surrounding Decentralized Clinical Trials
How heavily do decentralized clinical trials rely on technology? We asked Craig Lipset, a leading expert in the field of decentralized clinical trials.
May
2023
eyesON | Decentralized Clinical Trials Outlook: USA
Data visualization tool designed to identify untapped opportunities for Decentralized Clinical Trials advancement in the oncology sector in the USA.
May
2023
Big Pharma M&As: Is It Worth the Trouble?
Big Pharma M&As: A Worthwhile Challenge? Navigating the complex landscape of M&As in the pharmaceutical industry comes with unique objectives and potential benefits. But do these transactions truly drive shareholder value for the acquiring firm?
Apr
2023
eyesON | Big Pharma M&As: Clinical Trials Data Visualization
Users can explore the impact of M&As on pharma companies, by examining how it affects their number of ran clinical trials, R&D spending, and share prices.
Apr
2023
Global Impact of COVID-19 Pandemic on Clinical Trials
Wondering how the COVID-19 pandemic has impacted clinical trials worldwide? The COVID-19 pandemic has brought unprecedented challenges to the healthcare industry worldwide. The clinical trial sector has been no exception, and it has undergone significant changes over the past few years. From the [...]